BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 833472)

  • 1. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
    Grundy SM; Mok HY
    J Lab Clin Med; 1977 Feb; 89(2):354-66. PubMed ID: 833472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia.
    Grundy SM
    J Clin Invest; 1975 Feb; 55(2):269-82. PubMed ID: 233943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.
    Goodman DS; Noble RP; Dell RB
    J Clin Invest; 1973 Oct; 52(10):2646-55. PubMed ID: 4729058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of obesity and caloric intake on biliary lipid metabolism in man.
    Bennion LJ; Grundy SM
    J Clin Invest; 1975 Oct; 56(4):996-1011. PubMed ID: 1159099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA; Heimann KW
    S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man.
    Pertsemlidis D; Panveliwalla D; Ahrens EH
    Gastroenterology; 1974 Apr; 66(4):565-73. PubMed ID: 4821079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)].
    Briani G; Fellin R; Balestrieri P; Baggio G; Baiocchi MR; Crepaldi G
    G Ital Cardiol; 1975; 5(3):390-404. PubMed ID: 1149965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia.
    Grundy SM; Ahrens EH; Salen G; Schreibman PH; Nestel PJ
    J Lipid Res; 1972 Jul; 13(4):531-51. PubMed ID: 5041275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate.
    Kutz K; Schulte A
    Z Gastroenterol; 1981 May; 19(5):231-6. PubMed ID: 7257479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol and bile acid absorption during bile acid therapy in obese subjects undergoing weight reduction.
    Mok HY; Grundy SM
    Gastroenterology; 1980 Jan; 78(1):62-7. PubMed ID: 7350036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
    Vecchio TJ; Linden CV; O'Connell MJ; Heilman J
    Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of colestipol when combined with clofibrate in the treatment of severe hyperlipidemia. Short-term and long-term studies.
    Lithell H; Vessby B; Boberg J; Hellsing K
    Atherosclerosis; 1980 Oct; 37(2):175-86. PubMed ID: 7000089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resin.
    Rose HG; Haft GK; Juliano J
    Atherosclerosis; 1976; 23(3):413-27. PubMed ID: 178325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
    Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO
    Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin.
    Glueck CJ; Fallat RW; Mellies M; Tsang RC
    Pediatrics; 1976 Jan; 57(1):68-74. PubMed ID: 174057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ethinyl estradiol and phenobarbital on bile acid synthesis and biliary bile acid and cholesterol excretion.
    Davis RA; Kern F
    Gastroenterology; 1976 Jun; 70(6):1130-5. PubMed ID: 1269874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia.
    Glueck CJ; Mellies MJ; Dine M; Perry T; Laskarzewski P
    Pediatrics; 1986 Aug; 78(2):338-48. PubMed ID: 3526270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of gemfibrozil administration on biliary lipid secretion in hyperlipidemic patients. A crossover study with clofibrate.
    Mazzella G; Bazzoli F; Villanova N; Simoni P; Festi D; Roda A; Aldini R; Roda E
    Scand J Gastroenterol; 1990 Dec; 25(12):1227-34. PubMed ID: 2274744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
    Hunninghake DB; Bell C; Olson L
    Metabolism; 1981 Jun; 30(6):610-5. PubMed ID: 7231198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neomycin alone and in combination with cholestyramine on serum cholesterol and fecal steroids in hypercholesterolemic subjects.
    Miettinen TA
    J Clin Invest; 1979 Nov; 64(5):1485-93. PubMed ID: 387820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.